These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20922528)

  • 1. Costs of managing severe immune thrombocytopenia in adults: a retrospective analysis.
    Khellaf M; Le Moine JG; Poitrinal P; Francesconi C; Haddad A; Bierling P; Michel M; Eckert L; Launois R; Godeau B
    Ann Hematol; 2011 Apr; 90(4):441-6. PubMed ID: 20922528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the impact and burden of illness of adult chronic ITP in the US.
    Saleh MN; Fisher M; Grotzinger KM
    Curr Med Res Opin; 2009 Dec; 25(12):2961-9. PubMed ID: 19835465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy.
    Simpson KN; Coughlin CM; Eron J; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):58-64. PubMed ID: 9523750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
    Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
    Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of idiopathic thrombocytopenic purpura in adults: efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia].
    Pugina SA; Evdokimova NM; Rastorguev GG; Samoĭlova OS; Sorokina IV; Sidnev GV; Vasil'ev DM; Anastasiev VV; Milovidova OV; Molodovskaia EV; Borovkov NN
    Ter Arkh; 1999; 71(8):50-4. PubMed ID: 10515038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective observational single-centre study on the burden of immune thrombocytopenia (ITP).
    Bauer M; Baumann A; Berger K; Ackermann B; Shlaen R; Schopohl D; Ostermann H
    Onkologie; 2012; 35(6):342-8. PubMed ID: 22722454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
    Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
    Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y; Amin KG; Mohan K; Ahmed AR
    Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of vinca alkaloids in preparation for splenectomy of corticosteroid refractory chronic immune thrombocytopenic purpura patients.
    Szczepanik AB; Sikorska A; Slomkowski M; Konopka L
    Int J Lab Hematol; 2007 Oct; 29(5):347-51. PubMed ID: 17824915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab chimeric anti-CD20 monoclonal antibody treatment for adult refractory idiopathic thrombocytopenic purpura.
    Braendstrup P; Bjerrum OW; Nielsen OJ; Jensen BA; Clausen NT; Hansen PB; Andersen I; Schmidt K; Andersen TM; Peterslund NA; Birgens HS; Plesner T; Pedersen BB; Hasselbalch HC
    Am J Hematol; 2005 Apr; 78(4):275-80. PubMed ID: 15795920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct hospital resource utilization and costs of treating patients with multiple myeloma in Southwest Sweden: a 5-year retrospective analysis.
    Ghatnekar O; Alvegård T; Conradi N; Lenhoff S; Mellqvist UH; Persson U; Löthgren M
    Clin Ther; 2008 Sep; 30(9):1704-13. PubMed ID: 18840377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous immune globulin use in patients with human immunodeficiency virus-related thrombocytopenia who require dental extraction.
    Rarick MU; Burian P; de Guzman N; Espina B; Montgomery T; Jamin D; Levine AM
    West J Med; 1991 Dec; 155(6):610-2. PubMed ID: 1812630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible lower rate of chronic ITP after IVIG for acute childhood ITP an analysis from registry I of the Intercontinental Cooperative ITP Study Group (ICIS).
    Tamminga R; Berchtold W; Bruin M; Buchanan GR; Kühne T
    Br J Haematol; 2009 Jul; 146(2):180-4. PubMed ID: 19466971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical and non-medical direct costs of chronic low back pain in patients consulting primary care physicians in France.
    Depont F; Hunsche E; Abouelfath A; Diatta T; Addra I; Grelaud A; Lagnaoui R; Molimard M; Moore N
    Fundam Clin Pharmacol; 2010 Feb; 24(1):101-8. PubMed ID: 19678853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura.
    Kumar M; Vik TA; Johnson CS; Southwood ME; Croop JM
    Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Introduction of laparoscopic splenectomy for the treatment of immune thrombocytopenic purpura].
    Kiudelis M; Endzinas Z; Mickevicius A; Reckauskas M
    Zentralbl Chir; 2004 Apr; 129(2):108-13. PubMed ID: 15106041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Costs of haematological adverse events in chronic myeloid leukaemia patients: a retrospective cost analysis of the treatment of anaemia, neutropenia and thrombocytopenia in patients with chronic myeloid leukaemia.
    Bouwmans C; Janssen J; Huijgens P; Uyl-de Groot C
    J Med Econ; 2009 Jun; 12(2):164-9. PubMed ID: 19606951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of immune-mediated thrombocytopenia purpura with concurrent intravenous immunoglobulin and platelet transfusion: a retrospective review of 40 patients.
    Spahr JE; Rodgers GM
    Am J Hematol; 2008 Feb; 83(2):122-5. PubMed ID: 17874448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.